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Abstract
Objectives. To estimate the consultation incidence of OA using population-based health care data in
England and compare OA incidence figures with those derived in other countries.
Methods. A population-based health care database (Consultations in Primary Care Archive) in England
was used to derive the consultation incidence of OA (overall and by joint site) using the maximum
available run-in period method. These estimates, and their distribution by age and sex, were compared
with those published from population-based health care databases in Canada, the Netherlands and Spain.
A novel age-stratified run-in period method was then used to investigate whether the consultation inci-
dence has been increasing over time in younger adults.
Results. The annual consultation incidence of OA (any joint) was 8.6/1000 persons 515 years of age
(95% CI 7.9, 9.3) [6.3 (95% CI 5.5, 7.1) in men and 10.8 (95% CI 9.8, 12.0) in women]. Incidence increased
sharply between 45 and 64 years of age, peaking at 7584 years. The joint-specific incidence was 1.4
(95% CI 1.1, 1.7), 3.5 (95% CI 3.1, 3.9) and 1.3 (95% CI 1.1, 1.6) for hip OA, knee OA and hand OA,
respectively. The estimates and their distribution by age and sex were broadly consistent with international
estimates. Between 2003 and 2010, incidence in those aged 3544 years increased from 0.3 to 2.0/1000
persons.
Conclusion. Newly diagnosed cases of OA in England occur in 9 in 1000 at-risk adults each year, similar
to other international estimates. Although lower, the consultation incidence proportion in younger adults
appears to have increased in the past decade.
Key words: osteoarthritis, incidence, population-based health care data, consultation.
Rheumatology key messages
. Approximately 9 in 1000 persons aged 515 years is newly diagnosed with OA each year in England.
. An increase in England in newly diagnosed OA observed between 2003 and 2010 in 35- to 44-year-olds warrants
further investigation.
Introduction
OA accounts for 3% of all years lived with disability in
the high-income countries [1]. An ageing population,
increasing prevalence of risk factors such as obesity
and increasing strain on health budgets, including costs
of increasing numbers of patients undergoing joint
arthroplasty [2, 3], suggest a growing challenge for popu-
lation health, the National Health Service and the UK
economy [4].
A key recommendation of the UK Chief Medical Officer
is the need for better information in musculoskeletal
disorders [5]. Alongside the National Joint Registry
(http://www.njrcentre.org.uk/) and bespoke surveys and
cohorts, population-based health care databases based
on anonymized, routinely collected clinical information
recorded in the electronic health record are important
sources of such information, whose advantages in terms
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of representativeness, cost, size and continuity over time
are well recognized.
Data from general practice—the setting where most
cases of OA are assessed and managed—has been
used to estimate the consultation prevalence of OA (the
proportion of the population with a diagnosed consulta-
tion over a defined period of time) in several countries.
Fewer studies [610], and indeed none from the UK,
have estimated consultation incidence (the rate of new
cases presenting to general practice). Yet incidence
rates are an important measure of occurrence in the
population, responding more quickly to changes in risk
factors and being less influenced by disease duration
[11]. Previous estimates from Canadian provincial health
care databases would suggest an annual consultation
incidence for OA in men and women of 9.312.2/1000
and 11.017.4/1000, respectively [7, 9, 10]. Recent esti-
mates from a large regional primary care database in
Spain found a 3-fold higher incidence of knee OA than
hip or hand OA (6.5 vs 2.4 and 2.1/1000 persons >45
years of age) [8]. However, direct international compari-
sons are limited by different OA case definitions and
population strata. In addition, these previous estimates
cannot be assumed to be representative of current rates
in the UK since consultation incidence proportions for OA
may be influenced by cohort and period effects, some of
which may be particular to location (e.g. the effect of the
UK Quality and Outcomes Framework on coding of OA
since 2004).
One of the methodological challenges in estimating inci-
dence is how to ensure prevalent cases (those with pre-
vious OA consultations) are excluded from the calculation.
This is achieved in many databases by using a run-in
period (disease-free observation period [12], look-back
period [13] or clearance period [14]), which for OA can
be at least 9 years [15] (e.g. one needs to look back to
2001 to be confident that a patient consulting with OA in
2010 is receiving that diagnosis for the first time). One
disadvantage of this is that databases must be estab-
lished with satisfactory data quality for many years
before trends in incidence can begin to be described
[16]. However, we propose that prevalent cases can be
effectively excluded using shorter run-in periods in
younger age groups since they are less likely to have a
long prior history of OA consultations. Therefore our study
had two main objectives: first, to estimate the consultation
incidence of OA (overall and separately for hip, knee and
hand) by applying a maximum available (10 year) run-in
period to data from a local primary care database in North
Staffordshire, England and compare OA incidence figures
with those derived in other countries; second, in the same
database, to develop a novel age-stratified run-in period
method and demonstrate its application by testing the
hypothesis that there has been an increase in the consul-
tation incidence proportion of diagnosed OA among
younger adults (ages 3544 years; i.e. the 10 year age
band below the typical age stated in guidelines for clinical
diagnosis of OA [17]). Although the incidence of OA in this
age group is lower than in older age groups, increasing
incidence of OA over time in this age group could be of
particular concern in the context of increasing childhood
obesity.
Methods
Data source
The Consultations in Primary Care Archive (CiPCA), which
contains all recorded consultation data by general practi-
tioners (GPs) and practice nurses from 11 general prac-
tices in North Staffordshire, England between 2000 and
2010 (total practice population consisted of 94 955 people
in 2010) [16]. North Staffordshire is more deprived than
England as a whole, although the CiPCA practices cover
both deprived and less deprived areas. In England, gen-
eral practice provides the first point of access to the
National Health Service for most non-emergency care
and also provides continuing care for many chronic dis-
eases. The vast majority of the population are registered
at a general practice [18, 19]. Within CiPCA practices,
97% of contacts with a GP are assigned a morbidity
code and practices undergo an annual cycle of assess-
ment, feedback and training in morbidity coding [20]. A
similar annual primary care consultation prevalence
figure for OA from CiPCA practices has been shown com-
pared with those derived from national UK [21] and inter-
national (Swedish [16]) databases. Moreover, in CiPCA,
secondary care information (e.g. hospital letters) is
obtained and coded at the discretion of the practices,
thus completeness varies by practice.
Ethical approval for the CiPCA database was given by
the North Staffordshire Research Ethics Committee to
download, store and analyse anonymized medical records
information for research use from participating general
practices in CiPCA (reference 03/04). Patients are
informed by a poster at their GP’s practice and by leaflet
that the practice is a Keele research practice and that their
anonymized records (with identifiable information
removed) may be used for research, and that they can
opt out if they wish by informing the practice staff.
Therefore no separate ethical approval was required for
our study.
Case definition
An OA consultation was defined as a Read code starting
with N05 (OA and allied disorders), equivalent to ICD9
codes beginning with 715. Knee, hip and hand OA were
each defined by Read code lists drawn up through a con-
sensus process involving local GPs (code lists are avail-
able upon request from the authors [22]). A single medical
contact with an OA diagnosis is a standard definition used
in most previous studies [6, 23] and is preferred in pre-
vious validation studies to case definitions based on multi-
ple contacts, referrals and prescription records [24, 25].
Prieto-Alhambra et al. [8] report that only 1.3% of cases
defined in this way are subsequently given an alternative
diagnosis.
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Estimating consultation incidence using maximum
available run-in period
The overall annual consultation incidence of OA and inci-
dence rates by age (defined as age on 31 December 2010)
and sex were estimated for the calendar year 1 January
2010 to 31 December 2010. The numerator for the inci-
dence calculation was defined as those with a recorded
OA code in 2010 with no prior OA code and complete
registration in the previous 10 years. Hence prevalent
cases who were diagnosed with OA during the 10 year
run-in period from 1 January 200031 December 2009
were not eligible to be included in the numerator. Each
patient continuously registered in 2010 and for the run-in
period (1 January 200031 December 2009) was included
in the denominator, with exclusion of those who were pre-
valent cases in the run-in period. The incidence propor-
tions were then corrected for the loss of patients with <10
years registration (supplementary Tables S1S24, avail-
able at Rheumatology Online). A previous study of con-
sultation incidence of OA using health administrative data
in British Columbia, Canada concluded that a run-in
period of 9 years [10] was generally sufficient to remove
prevalent cases. We verified that the 10 year run-in period
(the maximum available within CiPCA) was sufficient to
observe a stable estimate of consultation incidence in
CiPCA by rerunning the analyses varying the run-in
period from 0 to 9 years (see supplementary Fig. S1, avail-
able at Rheumatology Online).
Using the maximum run-in period method, the consul-
tation incidence of OA was estimated for the total popula-
tion, among people 515 years of age and among people
545 years of age, as was consultation incidence of OA by
gender and specific age. All analyses were repeated for
OA in three selected body regions. We then compared the
consultation incidence of OA in women with that in men
using overall (age-adjusted) and age-specific female:male
incidence rate ratios (IRRs) with 95% CIs using Poisson
regression.
Comparison with international estimates
An earlier rapid literature review by us identified six origi-
nal English-language articles that reported potentially
comparable OA incidence estimates from 10 databases
in Canada, the Netherlands and Spain [6, 810, 26]
(supplementary Table S25, available at Rheumatology
Online). Using tables and plots we compared these inter-
national estimates with those obtained in the present
study using the maximum available run-in period
method in CiPCA. To facilitate the comparisons, direct
standardization was used, in which the published age-
stratified incidence rates from other international studies
were applied to the agesex distribution of the CiPCA
population.
Trend in consultation incidence of OA in
younger adults
A novel age-stratified run-in period method (supplemen-
tary data, the time series regression model for deriving
age-stratified run-in periods section, and supplementary
Fig. S2, available at Rheumatology Online) was used to
investigate the recent trend in annual consultation inci-
dence of OA among adults aged 3544 years. Since this
age group had the lowest minimum run-in period of all age
groups, more data points were available to evaluate
trends. The annual incidences in 200310 were estimated
and the trend was observed by fitting a log-linear model
with Wald test to test for linear trend. To increase the
stability of the rates with a minimum loss of information,
3 year moving average incidence proportions for 200510
were estimated by using the mean annual number of inci-
dent cases and mean denominator population over the 3
years. Statistical analyses were carried out using Stata
12.0 (StataCorp, College Station, TX, USA).
Results
On 1 January 2010, 94 955 people (48 237 women, 46 718
men) including 1953 people with a recorded OA diagnosis
(1251 women, 702 men) were registered in CiPCA.
Annual consultation incidence of OA
Based on the maximum available run-in period method,
the annual consultation incidence of OA at any joint for
persons aged 515 years was 8.6/1000 persons (95% CI
7.9, 9.3) [6.3 (95% CI 5.5, 7.1) for men and 10.8 (95% CI
9.8, 12.0) for women]. In those aged 545 years, the cor-
responding estimates were 16.1 (95% CI 14.8, 17.5), 12.0
(95% CI 10.5, 13.7) and 20.1 (95% CI 18.1, 22.2), respec-
tively (Table 1). The consultation incidence proportions,
expressed per 1000 persons aged 515 years, were 3.5
(95% CI 3.1, 3.9) for knee OA, 1.4 (95% CI 1.1, 1.7) for hip
OA and 1.3 (95% CI 1.1, 1.6) for hand OA.
Age- and gender-specific consultation incidence
estimates are shown in Fig. 1 (see also supplementary
Table S26, available at Rheumatology Online). Similar pat-
terns of age-specific consultation incidence were found
for OA at any joint, hip, knee and hand OA: a progressive
increase from age 25 to 34 years, with the steepest
change in slope for age group 5564 years, peaking at
7584 years, with a slight decrease in the age group
585 years. The pattern of age-specific consultation inci-
dence was similar between men and women at any joint,
knee and hand OA except hip OA, which showed an ear-
lier peak in men than in women. The consultation inci-
dence of OA was significantly higher in women, with the
exception of knee OA: age-adjusted IRR 1.6 (95% CI 1.3,
1.9) for OA at any joint, 1.6 (95% CI 1.0, 2.5) for hip OA,
1.0 (95% CI 0.7, 1.2) for knee OA and 3.3 (95% CI 2.0, 5.4)
for hand OA. There was no strong evidence that the fema-
le:male IRRs differed across age strata. At age 5564
years, a higher consultation incidence of knee OA was
noted among men compared with women (10.2/1000 per-
sons vs 5.9/1000 persons), although all such age- and
sex-stratified joint-specific estimates were based on
small numbers (see supplementary Table S27, available
at Rheumatology Online).
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Comparison with international estimates
The estimates from CiPCA were broadly comparable to
previously published international studies (Table 2), but
with some exceptions. While the overall estimate for the
total population fell within the range reported recently for
Dutch general practice research networks [26], in the
population 545 years of age the estimates from CiPCA
were substantially lower than those reported from the
Medical Service Plan health administrative database in
British Columbia [10]. Incidence continued to rise sharply
with age >50 years in the British Columbia study, in con-
trast to the slowing or levelling off seen in CiPCA and
another provincial health administrative database from
Alberta, Canada (supplementary Fig. S3A, available at
Rheumatology Online) [9]. Estimates for hip and knee OA
were noticeably higher in CiPCA than from the second
Dutch National Survey of General Practice in 2001. In con-
trast, there was generally fairly close agreement between
CiPCA and a large Catalan general practice database [8]
for joint-specific consultation incidence estimates for the
population aged54045 years as well as similar age and
gender patterns (supplementary Fig. 3B, available at
Rheumatology Online). An exception was the relatively
high consultation incidence in CiPCA for knee OA
among men.
Age-stratified run-in period method
The age-stratified run-in period method resulted in esti-
mates very similar to those obtained from the maximum
run-in period method when restricted to the population
515 years or545 years (supplementary Table S28, avail-
able at Rheumatology Online). For example, the consulta-
tion incidence of OA estimated by the age-stratified run-in
period method was 9.2 (95% CI 8.5, 9.9) for OA at any
joint, 1.2 (95% CI 1.0, 1.4) for hip OA, 3.6 (95% CI 3.2, 4.0)
for knee OA and 1.1 (95% CI 0.9, 1.4) for hand OA among
those 515 years of age.
Trend in consultation incidence of OA in younger
adults
The annual consultation incidence proportions of OA in
those 3544 years of age from 2003 to 2010 are presented
graphically in Fig. 2, along with the 3 year moving average.
The trend analysis revealed a linear increasing trend
(P= 0.0173) from an estimated annual consultation inci-
dence of 0.3/1000 (95% CI 0.1, 0.8) in 2003 to 2.0/1000
(95% CI 1.3, 2.9) in 2010.
Discussion
To our knowledge, this is the first study to estimate the
consultation incidence for OA using UK population-based
health care data. We found that 1 in 100 adults is newly
diagnosed with OA during the course of a year, rising to
3% of adults aged 7584 years. Our novel age-stratified
method for determining incidence revealed a trend of
increasing incidence of recorded cases of OA among
adults aged 3544 years.T
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FIG. 1 Annual age-specific consultation incidence (per 1000 persons) of OA (any joint and by selected body region),
overall and by gender: CiPCA 2010 [calculated using the maximum available (10 year) run-in period method]
(A) OA (any joint); (B) hip OA; (C) knee OA; (D) hand OA. CiPCA: Consultations in Primary Care Archive.
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Our estimates were generally within the range reported
by previous international studies, although an area of dis-
agreement concerns the relationship between OA consul-
tation incidence and age. Previous studies have reported
conflicting findings, showing either a steep, continuous
increase in incidence with age [10] or a marked decline
from the age of 6079 years [9]. Our study suggested a
plateau in incidence rates for men at age 6574 years and
an increase in women up to age 7584 years. The exact
reason for the differences in findings between studies is
unclear and further studies in other databases using com-
parable methods are required. Differences in coding
behaviour between UK primary care and Canadian admin-
istrative data, differences in the size of the denominator
population for the very old age groups, the inclusion of
comprehensive linked hospital data [10] and the use of a
power function to model very long run-in periods [9] in the
Canadian datasets may each contribute. In the UK, health
conditions that are incentivized within the General Medical
Services contract are likely to be more frequently diag-
nosed and recorded when present than non-incentivized
conditions [27]. A consequence of this could be under-
recording of OA and an apparent reduction in the
consultation incidence proportion of OA, particularly in
older adults with multimorbidity [28]. However, a levelling
off or decline in incidence rates for hand, knee and hip OA
after the age of 80 years has been reported in US data
using case definitions based on symptoms and radio-
graphs [29]. Nevertheless, as has been argued before
[15, 30], this pattern of declining incidence in later
life must be cautiously interpreted since it may reflect
biases due to competing risks, that is, individuals who
would have been at high risk of incident OA in later life
[30] may also have a higher mortality rate and thus may be
lost to follow-up.
The observed trend in incidence among those 3544
years old is potentially significant but must be interpreted
with caution. An OA diagnosis at this age is both uncom-
mon and potentially significant, with the age threshold
conventionally used for a working diagnosis of OA being
45 years [31], implying that this younger age group with
early onset has the prospect of several decades of living
with the condition. However, the consultation incidence of
diagnosed OA plainly does not equate to the incidence of
pathology or even of symptoms [32, 33]. Instead, consul-
tation incidence represents an event in the course of a
patient’s experience of associated symptoms and is
determined by their decision to consult and the GP’s
FIG. 2 Annual consultation incidence (per 1000 persons) of OA (any joint) among people aged 3544 years between 2003
and 2010: CiPCA 2010 (calculated using the age-stratified run-in period method)
CiPCA: Consultations in Primary Care Archive. Grey bars represent annual consultation incidence; black line represents
3-year moving average.
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decision to make and record the diagnosis of OA.
Observed trends may be due to changes in the thresholds
for these decisions and other aspects of data quality.
Although there is evidence from other primary care data-
bases in the UK that the number of recorded general
practice consultations per person-year has been increas-
ing [34, 35], this has been less marked in younger age
groups and the magnitude of this appears unlikely to
explain the trend we observed. More diligent recording
of secondary diagnoses and a lowering of the threshold
among practitioners for making the diagnosis of OA (as
opposed to using non-specific codes such as knee pain)
may contribute to this trend. However, we observed the
same trend of increasing incidence in adults aged 3544
years when restricting the analysis to diagnoses made in
primary care (data not shown). Between 199697 and
200304, Kopec et al. [7] found no evidence of an
increased consultation incidence of OA in persons <40
years of age in British Columbia. However, we cannot
exclude the possibility that our findings reflect a true secu-
lar change between 2003 and 2010 in the incidence of OA
in adults aged 3544 years. These cohorts grew up during
periods of increasing prevalence of obesity in England
[3638], which would be expected to increase the risk of
OA [39]. The contribution of injury, another important
determinant of OA in younger ages, is unclear due to a
lack of available data on representative populations.
The higher incidence of knee OA in men than in women
in the 5564 year age band was unexpected. This may be
a chance finding based on multiple comparisons and rela-
tively small numbers of incident cases within each
agegender stratum, although it is consistent with pre-
vious consultation prevalence in this age group [40] and
radiographical OA [41] in the population.
Administrative databases and electronic health care
records data are increasingly recognized as key resources
for chronic disease research and surveillance [42, 43]. OA
is underrepresented in these fields given its importance to
population health [1, 4]. One recurrent concern, shared
with all secondary uses of data recorded principally for
administrative or clinical purposes, is the validity of OA
case definitions. A variety of approaches have been
undertaken in our and other databases internationally,
including manual review of anonymized free text in the
health record, typically adjudicated by one or more clin-
icians [4446], comparison of rates in different databases
[17, 21], comparison with independent patient self-reports
[24, 25, 47] and clinical or imaging assessment [48]. As
with other data sources [49], incidence and prevalence
estimates derived from administrative and health record
data are sensitive to the particular case definition adopted
[10]. While a single record of a consultation with an OA
diagnostic code has been supported in some of these
studies [24, 25, 47], and is the most commonly used
case definition, it must nevertheless be acknowledged
as naive in that it assumes no misclassification errors
[50]. Uncertainty around our estimates is likely to be
greater than implied by the CIs and, together with the
relatively small size of the database, means that our
findings should be replicated in other similar databases.
If confirmed, an increase in newly diagnosed cases of OA
in younger adulthood may have important but quite differ-
ent implications depending on whether it reflects a low-
ering of the diagnostic threshold or the earlier onset of
OA. Distinguishing between these two interpretations war-
rants further investigation. Secondary care information
(e.g. hospital letters) is recorded and coded in CiPCA,
but the completeness of this information will vary by prac-
tice. While it is unlikely (due to the generally long run-in
periods that we have used) that many patients with an
existing diagnosis of OA during the run-in period would
not be identified in CiPCA, the number of new cases of OA
in 2010 may be conservative since there may be some
patients diagnosed in secondary care who were not
recorded with OA in CiPCA.
Our estimates of the rate and agesex distribution of new
OA diagnoses, showing broad consistency with incidence
rates derived internationally, help to address an information
gap on OA occurrence in the UK. A novel method,
designed to more efficiently use data within routine electro-
nic health care databases, has provided preliminary data
on a trend likely to be of public health concern but which
these data alone cannot answer conclusively.
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